News
Press Center
Boehringer Ingelheim has concluded phase one of their localization effort aimed at manufacturing their innovative thrombolytic medicines in Russia: the first batches of Metalyse (tenectaplase) for acute heart attack treatment were produced at NPO Petrovax Pharm facilities.
More
Topics Petrovax Pharm The Nongovernmental Pension Fund (NPF) Interros-Dostoinstvo Board Meeting decided toassign control over the Fund toOJSC MMC Norilsk Nickel.
More
Topics Norilsk Nickel / Interros-Dostoinstvo